北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study
作者: Cao, Kegang1; Yu, Lihua2; Gao, Ying1; Fan, Yongping3; Zhao, Jianjun4; Zhang, Xuezhi5; Xie, Wei6; Yang, Wenming7; Dong, Mengjiu8; Li, Tao9; Qiao, Xiangyang10
关键词: Zhengtian Pill ; Migraine prophylaxis ; Clinical efficacy ; Safety ; Randomized controlled trial ; Chinese herbal medicine
刊名: EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
发表日期: 2014-06-01
DOI: 10.1016/j.eujim.2014.01.005
卷: 6, 期:3, 页:259-267
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Integrative & Complementary Medicine
研究领域[WOS]: Integrative & Complementary Medicine
关键词[WOS]: QUALITY-OF-LIFE ; CONTROLLED-TRIAL ; HEADACHE ; ACUPUNCTURE ; PREVALENCE ; DISABILITY ; DIAGNOSIS ; DISEASE ; BURDEN ; ATTACK
英文摘要:

Introduction: Migraine is a common neurological disorder characterized by recurrent headache attacks. Migraine treatment involves acute and prophylactic therapy. The objective of this study is to evaluate the efficacy and safety of Zhengtian Pill for migraine prophylaxis.

Methods: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study was carried out to compare the efficacy and safety of Zhengtian Pill versus placebo. A total of 247 subjects were enrolled in this study and 219 were randomized in a 1:1 ratio of Zhengtian Pill to placebo groups. After a four-week baseline period, subjects were administered Zhengtian Pill or placebo orally at a dose of 6 g, three times daily for 12 weeks. Changes from baseline in the frequency of migraine attacks, the number of days with migraine, migraine attack duration, and the number of days of acute migraine medication per four weeks in the intent-to-treat (ITT) and per-protocol (PP) populations were analyzed. The safety of Zhengtian Pill versus placebo was evaluated in the safety-evaluable population.

Results: After 12 weeks of treatment, Zhengtian Pill significantly reduced the frequency of migraine attacks, the number of days with migraine, migraine attack duration, and the number of days of acute migraine medication per four weeks in the ITT and PP populations compared with placebo. The proportion of patients experiencing any adverse event was similar between both treatment groups. Adverse events caused by Zhengtian Pill were generally mild.

Conclusions: Our results demonstrate that Zhengtian Pill can be considered as an effective and safe Chinese patent medicine for migraine prophylaxis. (C) 2014 Elsevier GmbH. All rights reserved.

语种: 英语
所属项目编号: 2007BAI20B053
项目资助者: National Science and Technology Infrastructure Program ; China Resources Sanjiu Medical &amp ; Pharmaceutical Co, Ltd.
WOS记录号: WOS:000341296300003
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/63825
Appears in Collections:北京大学第一临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Neurol, Beijing 100700, Peoples R China
2.Beijing Univ Tradit Chinese Med, Hosp 3, Dept Emergency Med, Beijing 100029, Peoples R China
3.Capital Med Univ, Beijing Tiantan Hosp, Dept Chinese Tradit Med, Beijing 100050, Peoples R China
4.Changchun Univ Tradit Chinese Med, Hosp 1, Dept Neurol, Changchun 130021, Peoples R China
5.Peking Univ, Hosp 1, Dept Chinese Tradit Med, Beijing 100034, Peoples R China
6.Southern Med Univ, Nanfang Hosp, Dept Chinese Tradit Med, Guangzhou 510515, Guangdong, Peoples R China
7.Anhui Univ Tradit Chinese Med, Hosp 1, Dept Neurol, Hefei 230022, Anhui, Peoples R China
8.Hubei Hosp Tradit Chinese Med, Dept Neurol, Wuhan 430061, Hubei, Peoples R China
9.China Acad Chinese Med Sci, Xiyuan Hosp, Dept Neurol, Beijing 100091, Peoples R China
10.Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200431, Peoples R China

Recommended Citation:
Cao, Kegang,Yu, Lihua,Gao, Ying,et al. Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study[J]. EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE,2014,6(3):259-267.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Cao, Kegang]'s Articles
[Yu, Lihua]'s Articles
[Gao, Ying]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Cao, Kegang]‘s Articles
[Yu, Lihua]‘s Articles
[Gao, Ying]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!